Alexion Pharmaceuticals, Inc (ALXN)

Etorro trading 970x250
Alexion Pharmaceuticals, Inc (ALXN) Logo

About Alexion Pharmaceuticals, Inc

Alexion Pharmaceuticals, Inc. develops and commercializes various therapeutic products. The company offers ULTOMIRIS for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS); and SOLIRIS for the treatment of PNH, aHUS, generalized myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder (NMOSD). It also provides Strensiq for patients with hypophosphatasia; Kanuma (sebelipase alfa) for the treatment of patients with lysosomal acid lipase deficiency; and Andexxa, a reversal agent for patients treated with rivaroxaban or apixaban. In addition, the company is developing ALXN1210 (Intravenous) that is in Phase III clinical trials for the treatment of gMG, NMOSD, ALS, COVID-19, and HSCT-TMA; ALXN1210 (Subcutaneous), which is in Phase III clinical trials for PNH and aHUS; ALXN1820 that is in Phase I clinical trial, a therapeutic antagonist of properdin; and ALXN1720, which is in Phase I clinical trial for the treatment of disease states involving dysregulated terminal complement activity. Further, it is developing ALXN1840 that is in Phase III clinical trials for the treatment of Wilson disease; ALXN1830, which are in Phase I clinical trials for neonatal Fc receptor; ALXN2040 and ALXN2050 to treat diseases associated with dysregulation of the complement alternative pathway; ALXN1850, an enzyme replacement therapy; ALXN2060 for treating transthyretin amyloidosis; and ALXN2075 for treatment of relapsed/refractory chronic lymphocytic leukemia. The company serves distributors, pharmacies, hospital, hospital buying groups, and other healthcare providers in the United States and internationally. Alexion Pharmaceuticals, Inc. has collaboration and license agreement with Halozyme Therapeutics, Inc.; and agreements with Dicerna Pharmaceuticals, Inc., Zealand Pharma A/S, Caelum Biosciences, Inc., Stealth BioTherapeutics Corp., and Affibody AB. The company was founded in 1992 and is headquartered in Boston, Massachusetts. Address: 121 Seaport Boulevard, Boston, MA, United States, 02210

Alexion Pharmaceuticals, Inc News and around…

Latest news about Alexion Pharmaceuticals, Inc (ALXN) common stock and company :

Will Moderna’s Tenure on the S&P 500 Index Be Short-Lived?
01 Aug, 2021 FinancialContent

It's not likely.

This Drug's New Indication in China Will Be a Boost to AstraZeneca
30 Jul, 2021 FinancialContent

The new approval to treat a form of lung cancer will be pivotal to dominating a massive market.

AstraZeneca Wraps Its Massive Alexion Buyout — Is AZN Stock A Buy Or Sell?
23 Jul, 2021 Yahoo! Finance

AstraZeneca stock returned to an uptrend after the company finished its Alexion buyout. Is AZN stock a buy or a sell right now?

Alexion Pharmaceuticals (ALXN) Earnings Expected to Grow: Should You Buy?
22 Jul, 2021 Yahoo! Finance

Alexion (ALXN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ALXN vs. TECH: Which Stock Is the Better Value Option?
21 Jul, 2021 Yahoo! Finance

ALXN vs. TECH: Which Stock Is the Better Value Option?

Stock Market News For Today July 21, 2021
21 Jul, 2021 FinancialContent
Alexion's Ultomiris Sales Almost Doubles In 1H 2021 As $39B AstraZeneca Deal Looms
20 Jul, 2021 FinancialContent

Ultomiris, the successor toAlexion Pharmaceuticals Inc's(NASDAQ: ALXN) paroxysmal nocturnal hemoglobinuria (PNH) drug ...

AstraZeneca's Acquisition of Alexion Is Nearly a Done Deal, But Is It a Good Deal?
17 Jul, 2021 FinancialContent

Probably so.

With the Alexion Acquisition Set to Close This Quarter, Is AstraZeneca a Buy?
17 Jul, 2021 FinancialContent

With UK approval, the $39 billion deal for rare disorders biotech company Alexion Pharmaceuticals is set to close on July 21.

What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.
16 Jul, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips What did the stock market do today? It saw Moderna reach a major index, it saw Americans spending big, and it saw Biden targeting China. The post What Did the Stock Market Do Today? 3 Big Stories to Catch Up On. appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now It doesn’t matter if you have $500 in savings or $5 million. Do this now.

Moderna Options Traders Mixed On S&P 500 Inclusion
16 Jul, 2021 FinancialContent

Moderna, Inc (NASDAQ: MRNA) gapped up 6.64% Friday morning after it was announced the company will join theS&P ...

Alexion (ALXN) Reports Positive Data on Ultomiris From gMG Study
16 Jul, 2021 Yahoo! Finance

Alexion (ALXN) announces that the phase III study of Ultomiris for the indication of gMG met its primary goal.

This Nasdaq Vaccine Stock Just Got a Big Boost -- and Another Nasdaq Vaccine Stock Deserves the Credit
16 Jul, 2021 FinancialContent

Find out why a big index move is so interesting for investors.

MRNA Surges to Record High on Plans to Join S&P 500
16 Jul, 2021 FinancialContent

Moderna stock is set to join the benchmark on July 21, replacing Alexion Pharmaceuticals.

Why Moderna Stock Just Jumped 10%
16 Jul, 2021 FinancialContent

The company joins the S&P 500 index next week.

MRNA Stock: 10 Things to Know About Moderna as It Gets Ready to Join the S&P 500
16 Jul, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Moderna (MRNA) stock is on the rise Friday as the company prepares to join the S&P 500 next week replacing Alexion Pharmaceuticals (ALXN). The post MRNA Stock: 10 Things to Know About Moderna as It Gets Ready to Join the S&P 500 appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now It doesn’t matter if you have $500 in savings or $5 million. Do this now.

Alexion's Ultomiris Shows Compelling, Durable Efficacy In Rare Muscle Weakness Disorder
16 Jul, 2021 FinancialContent

Alexion Pharmaceuticals Inc(NASDAQ: ALXN)announced topline resultsfrom a Phase 3 study evaluating Ultomiris ...

Dow futures drift higher as investors watch for retail sales to end the week
16 Jul, 2021 FinancialContent

U.S. stock-index futures on Friday were trading slightly higher ahead of a data on June retail sales, after a week featuring assurances by Federal Reserve Chairman Jerome Powell that surging inflation was a temporary phenomenon.

Why Moderna Shares Are Rallying Today
16 Jul, 2021 FinancialContent

Shares of COVID-19 vaccine company Moderna, Inc. (NASDAQ: MRNA), which ended Thursday's session with a market cap of $104.3 billion ...

Moderna Stock Surges on News of Inclusion Into S&P 500 Next Week
16 Jul, 2021 Yahoo! Finance

By Dhirendra Tripathi

Top Stocks To Watch This Week? 4 Biotech Stocks To Know
16 Jul, 2021 FinancialContent
Moderna Set to Join S&P 500
15 Jul, 2021 Yahoo! Finance

Moderna Inc. (NASD:MRNA) will replace Alexion Pharmaceuticals Inc. (NASD:ALXN) in the S&P 500 effective prior to the opening of trading on Wednesday, July 21. AstraZeneca Plc (LSE:AZN; NASD:AZN) is acquiring Alexion Pharmaceuticals in a deal expected to be completed soon pending final closing conditions.

Moderna set to join S&P 500, stock rallies 8%
15 Jul, 2021 FinancialContent

Moderna Inc., a biotechnology company catapulted to notoriety after it produced a highly effective COVID-19 vaccine, is set to join the S&P 500 index, a seal of approval that will put the stock in countless index-tracking and actively managed funds and retirement accounts.

Alexion Announces Positive Topline Results from Phase 3 Study of ULTOMIRIS® (ravulizumab-cwvz) in Adults with Generalized Myasthenia Gravis (gMG)
15 Jul, 2021 FinancialContent

Alexion Announces Positive Topline Results from Phase 3 Study of ULTOMIRIS® (ravulizumab-cwvz) in Adults with Generalized Myasthenia Gravis (gMG).

Why Alexion Pharmaceuticals (ALXN) is a Top Momentum Stock for the Long-Term
15 Jul, 2021 Yahoo! Finance

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs
15 Jul, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Honeywell International Inc. to Join the NASDAQ-100 Index Beginning July 21, 2021
15 Jul, 2021 FinancialContent
Here is Why Growth Investors Should Buy Alexion (ALXN) Now
14 Jul, 2021 Yahoo! Finance

Alexion (ALXN) could produce exceptional returns because of its solid growth attributes.

Stocks That Hit 52-Week Highs On Wednesday
14 Jul, 2021 FinancialContent

Before 10 a.m. ET Wednesday, 81 stocks made new 52-week highs. Areas of Interest: Apple (NASDAQ:AAPL) was ...

AstraZeneca (AZN) Gets Clearance in UK for Alexion Acquisition
14 Jul, 2021 Yahoo! Finance

AstraZeneca (AZN) obtains UK Competition and Markets Authority's permission for the impending acquisition of Alexion. The deal is expected to close on Jul 21, 2021.

Alexion Pharmaceuticals, Inc (ALXN) is a NASDAQ Common Stock listed in , ,

970x250